BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8853551)

  • 61. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
    Chen L; Pulsipher M; Chen D; Sieff C; Elias A; Fine HA; Kufe DW
    J Clin Invest; 1996 Dec; 98(11):2539-48. PubMed ID: 8958216
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging.
    Seth P; Brinkmann U; Schwartz GN; Katayose D; Gress R; Pastan Ira ; Cowan K
    Cancer Res; 1996 Mar; 56(6):1346-51. PubMed ID: 8640824
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adenovirus p53 purging for human breast cancer stem cell products.
    Hirai M; Kelsey LS; Maneval DC; Vaillancourt M; Talmadge JE
    Acta Haematol; 1999; 101(2):97-105. PubMed ID: 10202240
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
    Sharp JG; Bishop MR; Copple B; Greiner TC; Iversen PL; Jackson JD; Joshi SS; Benner EJ; Mann SL; Rao AK; Vose JM
    Leuk Lymphoma; 2001 Jul; 42(3):417-27. PubMed ID: 11699407
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Knockdown of
    Hilgendorf S; Vellenga E
    Haematologica; 2018 Feb; 103(2):e59-e62. PubMed ID: 29101206
    [No Abstract]   [Full Text] [Related]  

  • 66. HeLa Cells: Contaminating Cultures around the World.
    Culliton BJ
    Science; 1974 Jun; 184(4141):1058-9. PubMed ID: 17736186
    [No Abstract]   [Full Text] [Related]  

  • 67. The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications.
    Tsang JJ; Atkins HL
    Oncolytic Virother; 2015; 4():13-23. PubMed ID: 27512666
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.
    Shayakhmetov DM; Papayannopoulou T; Stamatoyannopoulos G; Lieber A
    J Virol; 2000 Mar; 74(6):2567-83. PubMed ID: 10684271
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus.
    Wroblewski JM; Lay LT; Van Zant G; Phillips G; Seth P; Curiel D; Meeker TC
    Cancer Gene Ther; 1996; 3(4):257-64. PubMed ID: 8853551
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
    Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
    Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease.
    Meeker TC; Lay LT; Wroblewski JM; Turturro F; Li Z; Seth P
    Clin Cancer Res; 1997 Mar; 3(3):357-64. PubMed ID: 9815692
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX; Ngo D; Brade AM; Klamut HJ
    Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.